DYSPNEA
Clinical trials for DYSPNEA explained in plain language.
Never miss a new study
Get alerted when new DYSPNEA trials appear
Sign up with your email to follow new studies for DYSPNEA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
COVID-19 drug trial halted before it began
Disease control TerminatedThis study was designed to see if an inhaled medication called ZYESAMI could help people with severe COVID-19 avoid needing a breathing machine. The trial was planned for adults with low oxygen levels or rapid breathing, but it was withdrawn before any participants enrolled. No r…
Matched conditions: DYSPNEA
Phase: PHASE3 • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New study aims to simplify diagnosis of hidden heart failure
Diagnosis OngoingThis study looks at better ways to diagnose a type of heart failure called HFpEF in people who have shortness of breath but no clear cause. Researchers will compare simple tests to the standard invasive procedure to see which ones work best. The goal is to make diagnosis easier a…
Matched conditions: DYSPNEA
Sponsor: University of Leipzig • Aim: Diagnosis
Last updated May 11, 2026 20:49 UTC
-
Can a common steroid help cancer patients breathe easier?
Symptom relief OngoingThis study tests whether dexamethasone, a steroid, can reduce shortness of breath in people with cancer. About 135 patients with moderate to severe dyspnea and lung involvement are being treated and monitored for two weeks. The goal is to see if the drug improves breathing and qu…
Matched conditions: DYSPNEA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 26, 2026 05:29 UTC